Why is TP53 commonly mutated in human cancer?

16:00 EDT 8 Aug 2019 | ecancermedicalscience

A comprehensive functional analysis of TP53 mutations in human leukaemia may refute a working hypothesis - primarily based on mouse studies that missense mutations confer new cancer-causing functions to the p53 tumour suppressor protein. The study, which...

Original Article: Why is TP53 commonly mutated in human cancer?

More From BioPortfolio on "Why is TP53 commonly mutated in human cancer?"